Funding for this research was provided by:
Pfizer Oncology (Not applicable)
Text and Data Mining valid from 2020-05-01
Received: 21 January 2020
Accepted: 6 April 2020
First Online: 1 May 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: CK, ED, KD, VT and KVC report an unrestricted research grant from Pfizer Oncology to the institution irrespective of the research performed during this study.ER received honoraries for participating in advisory board meetings from AstraZeneca, BMS and Roche.NtH received honoraries for participating in advisory board meetings from Merck, Roche, Pfizer and AstraZeneca, and unrestricted research support from Roche and Pfizer.LB received honoraries for participating in advisory board meetings from Boehringer Ingelheim and AstraZeneca, and research support from Roche.CG reports reports personal fees from Astrazeneca for a workshop (2017) and board meeting (2018), outside the submitted work.PP received honoraries for participating in advisory board meetings from Biocartis, Boehringer Ingelheim, Roche, Novartis, Pfizer, Merck, MSD, Bristol-Myers Squibb and AstraZeneca, and research support from Roche and AstraZeneca.LT reports honoraria from Amgen for participation an advisory board in 2016.ET acted as consultant for MSD, Pfizer, Clovis, BMS, AZ, Diaceutics, Amgen, Abbvie, Roche Ventana, Bayer, Takeda, currently for ZZP and Histogenex. He has received honoraria for speaker AZ, Pfizer, Roche trainer SP142, SP263. The VUMC received grants from IIR Pfizer, Astra Zeneca.ES received honoraria for advisory board from AstraZeneca, Roche, Pfizer, Bayer, Novartis, BMS, BioRad, Illumina, Ageno BioSciences, Janssen Cilag (Johnson&Johnson), BioCartis; speaker’s fee AstraZeneca, Roche, Pfizer, Novartis, BioRad, Illumina, BioCartis; research support from Boehringer Ingelheim, BMS, Biocartis, BioRad, Ageno BioSciences and Roche (All outside the submitted work and fees to UMCG).PG, AL, AM, AR, JvdT, KZ, and BLW have nothing to declare.